Hannah was appointed EVP and Chief Medical Officer at Rigel Pharmaceuticals, Inc. on July 1, 2026.
1 report, 1 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Hannah was appointed EVP and Chief Medical Officer at Rigel Pharmaceuticals, Inc. on July 1, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Hannah
researcher ORCID ID = 0000-0002-6009-6484